In trading on Thursday, shares of Celldex Therapeutics, Inc. (CLDX) touched a new 52-week low of $9.66/share. That's a $23.16 share price drop, or -70.57% decline from the 52-week high of $32.82 set back on 03/19/2015. Large percentage drops always require that the stock post even larger percentage gains from the low in order to recover the old price point, and for CLDX that means the stock would have to gain 239.75% to get back to the 52-week high. For a move like that, Celldex Therapeutics, Inc. would need fundamental strength at the business level.Here's a rhetorical question: Who knows more about fundamentals at the business level than the company's own insiders? So let's take a look to see whether any company insiders were taking the other side of the trade as CLDX shares were being sold down to this new 52-week low, focusing on the most recent trailing six month period. As summarized by the table below, CLDX has seen 2 different instances of insiders buying over the past six months.
|08/13/2015||Anthony S. Marucci||President and CEO||5,800||$16.81||$97,497.42|
Time will tell whether the insider purchases foretell a future rebound for CLDX shares, which are presently showing a last trade of $10.90/share, a 12.84% rebound off of the new 52-week low.